Stock listing
A1XB6K Stock Price, News, Filings & Events — Heron Therapeutics, Inc.
Selected listing: A1XB6K · LS · EUR · DE
This page tracks Heron Therapeutics, Inc.'s A1XB6K:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1XB6K:LS. A1XB6K:LS is the stock-level entry point for investors researching Heron Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Heron Therapeutics, Inc. is a publicly traded company in the American market, with a market capitalization of approximately $86.3 million. The company focuses on developing innovative therapeutics to improve patient outcomes. Heron is committed to advancing its product pipeline and addressing unmet medical needs in various therapeutic areas.
- Ticker
- A1XB6K:LS
- Asset type
- Stock
- Market cap
- $62.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Heron Therapeutics, Inc. A1XB6K:LS stock context
This page tracks Heron Therapeutics, Inc.'s A1XB6K:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1XB6K:LS. A1XB6K:LS is the stock-level entry point for investors researching Heron Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Heron Therapeutics, Inc. is a publicly traded company in the American market, with a market capitalization of approximately $86.3 million. The company focuses on developing innovative therapeutics to improve patient outcomes. Heron is committed to advancing its product pipeline and addressing unmet medical needs in various therapeutic areas.
Latest news from Heron Therapeutics, Inc.
Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026
July 27, 2026
U.S. District Court Issues Decision Regarding CINVANTI® Patents
June 2, 2026
Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance
May 11, 2026
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
April 27, 2026
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
Heron Therapeutics, Inc. earnings calls
Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call
August 10, 2026 · Replay with transcript and chapters
Heron Therapeutics, Inc. (HRTX) Q1 2026 Earnings Call
May 11, 2026 · Replay with transcript and chapters
Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Heron Therapeutics, Inc. (HRTX) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Heron Therapeutics, Inc. (HRTX) Q2 2025 Earnings Call
August 11, 2025 · Replay with transcript and chapters
Heron Therapeutics, Inc. (HRTX) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Heron Therapeutics, Inc.
Heron Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A1XB6K:LS.
Heron Therapeutics, Inc. company profile
View the public company page for Heron Therapeutics, Inc. on 6ix.
Heron Therapeutics, Inc. news
Read company news and market updates connected to Heron Therapeutics, Inc..
Heron Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Heron Therapeutics, Inc..
Alternate listings
HRTX:NASDAQ
US · USD
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.
HRTX:BOATS
US · USD
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.
A1XB6K:LSX
DE · EUR
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.
0J4V:LSE
GB · USD
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.
AXD2:SWB
DE · EUR
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.
AXD2:GETTEX
DE · EUR
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.
AXD2:DUS
DE · EUR
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.
AXD2:FWB
DE · EUR
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.
AXD2:TRADEGATE
DE · EUR
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.
AXD2:BX
CH · CHF
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.
AXD2:MUN
DE · EUR
Alternate listing for Heron Therapeutics, Inc.; the primary context on this page is A1XB6K:LS.